VanEck Pharmaceutical ETF
PPH
PPH
106 hedge funds and large institutions have $355M invested in VanEck Pharmaceutical ETF in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 40 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
106
Holders Change
-8
Holders Change %
-7.02%
% of All Funds
1.7%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
14
Increased
21
Reduced
40
Closed
22
Calls
$5.35M
Puts
$1.02M
Net Calls
+$4.33M
Net Calls Change
+$1.46M
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$37.3M |
| 2 |
HF
HRT Financial
New York
|
+$4.82M |
| 3 |
JPMorgan Chase & Co
New York
|
+$3.92M |
| 4 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
+$3.23M |
| 5 |
WWM
WT Wealth Management
Scottsdale,
Arizona
|
+$2.51M |
Top Sellers
| 1 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$148M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$30.9M |
| 3 |
Goldman Sachs
New York
|
-$19.6M |
| 4 |
PCIA
Prime Capital Investment Advisors
Overland Park,
Kansas
|
-$11.8M |
| 5 |
LPL Financial
San Diego,
California
|
-$5.12M |